Top Midday Decliners

MT Newswires Live

Oct 14

Tvardi Therapeutics (TVRD) shares sank nearly 84% amid heavy trading after the company said Monday its phase 2 clinical trial of TTI-101 as a potential treatment for idiopathic pulmonary fibrosis failed to meet its goals.

Intraday trading volume jumped to over 5.55 million from a daily average of about 42,000.

Beyond Meat (BYND) said Monday its offer to exchange existing zero-interest convertible notes due in 2027 for new 7% secured notes due in 2030 and shares of common stock was subscribed with 96.92% of the holders tendering in for the exchange.

Shares slumped roughly 46% as intraday trading volume soared to nearly 117.5 million from a daily average of about 4.9 million.

Fastenal's (FAST) Q3 earnings came in below market estimates amid sluggish industrial production, while the company's sales rose in line with expectations.

Shares dropped 5.9% as intraday trading volume climbed to about 10.8 million from a daily average of roughly 6.3 million.

Price: 6.68, Change: -34.92, Percent Change: -83.94

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2575846382"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575846382\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575846382?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-14 02:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575846382","market":"nz","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Tvardi <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TVRD) shares sank nearly 84% amid heavy trading after the company said Monday its phase 2 clinical trial of TTI-101 as a potential treatment for idiopathic pulmonary fibrosis failed to meet its goals.</p><p>Intraday trading volume jumped to over 5.55 million from a daily average of about 42,000.</p><p><a href=\"https://laohu8.com/S/BYND\">Beyond Meat</a> (BYND) said Monday its offer to exchange existing zero-interest convertible notes due in 2027 for new 7% secured notes due in 2030 and shares of common stock was subscribed with 96.92% of the holders tendering in for the exchange.</p><p>Shares slumped roughly 46% as intraday trading volume soared to nearly 117.5 million from a daily average of about 4.9 million.</p><p>Fastenal's (FAST) Q3 earnings came in below market estimates amid sluggish industrial production, while the company's sales rose in line with expectations.</p><p>Shares dropped 5.9% as intraday trading volume climbed to about 10.8 million from a daily average of roughly 6.3 million.</p><p>Price: 6.68, Change: -34.92, Percent Change: -83.94</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-14 02:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Tvardi <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TVRD) shares sank nearly 84% amid heavy trading after the company said Monday its phase 2 clinical trial of TTI-101 as a potential treatment for idiopathic pulmonary fibrosis failed to meet its goals.</p><p>Intraday trading volume jumped to over 5.55 million from a daily average of about 42,000.</p><p><a href=\"https://laohu8.com/S/BYND\">Beyond Meat</a> (BYND) said Monday its offer to exchange existing zero-interest convertible notes due in 2027 for new 7% secured notes due in 2030 and shares of common stock was subscribed with 96.92% of the holders tendering in for the exchange.</p><p>Shares slumped roughly 46% as intraday trading volume soared to nearly 117.5 million from a daily average of about 4.9 million.</p><p>Fastenal's (FAST) Q3 earnings came in below market estimates amid sluggish industrial production, while the company's sales rose in line with expectations.</p><p>Shares dropped 5.9% as intraday trading volume climbed to about 10.8 million from a daily average of roughly 6.3 million.</p><p>Price: 6.68, Change: -34.92, Percent Change: -83.94</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4548","symbol_name":"巴美列捷福持仓","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2575846382","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575846382","pubTimestamp":1760379735,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Tvardi Therapeutics (TVRD) shares sank nearly 84% amid heavy trading after the company said Monday its phase 2 clinical trial of TTI-101 as a potential treatment for idiopathic pulmonary fibrosis fail","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4548":"巴美列捷福持仓","BK4212":"包装食品与肉类","BK4104":"贸易公司与经销商","FAST":"快扣","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","BK4007":"制药","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4588":"碎股","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","BK4567":"ESG概念","TVRD":"Tvardi Therapeutics Inc"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FAST":1,"TVRD":1},"content_text":"Tvardi Therapeutics (TVRD) shares sank nearly 84% amid heavy trading after the company said Monday its phase 2 clinical trial of TTI-101 as a potential treatment for idiopathic pulmonary fibrosis failed to meet its goals.Intraday trading volume jumped to over 5.55 million from a daily average of about 42,000.Beyond Meat (BYND) said Monday its offer to exchange existing zero-interest convertible notes due in 2027 for new 7% secured notes due in 2030 and shares of common stock was subscribed with 96.92% of the holders tendering in for the exchange.Shares slumped roughly 46% as intraday trading volume soared to nearly 117.5 million from a daily average of about 4.9 million.Fastenal's (FAST) Q3 earnings came in below market estimates amid sluggish industrial production, while the company's sales rose in line with expectations.Shares dropped 5.9% as intraday trading volume climbed to about 10.8 million from a daily average of roughly 6.3 million.Price: 6.68, Change: -34.92, Percent Change: -83.94","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}